Inmune Bio, Inc. (15)

Browse by Contract Category

Contracts

Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC (Filed With SEC on January 4, 2021)
Amendment to Exclusive License Agreement (Filed With SEC on November 5, 2020)
Amendment No. 1 to At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on August 19, 2020)
Underwriting Agreement, dated July 16, 2020, by and between INmune Bio, Inc. and BTIG, Inc., as representative of the underwriters named therein (Filed With SEC on July 16, 2020)
INmune Bio, Inc. 2019 Stock Incentive Plan (attached hereto) (Filed With SEC on March 11, 2020)
Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC (Filed With SEC on December 30, 2020)
At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on April 17, 2020)
Award Agreement dated as of February 4, 2020 (Filed With SEC on February 10, 2020)
Common Stock Repurchase Agreement (Filed With SEC on January 27, 2020)
Amendment No. 2 to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi (Filed With SEC on May 24, 2019)
Amendment to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi (Filed With SEC on May 17, 2019)
Amendment to Securities Purchase Agreement between INmune Bio, Inc. and David J. Moss (Filed With SEC on May 17, 2019)
Purchase Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC, dated May 15, 2019 (Filed With SEC on May 16, 2019)
Registration Rights Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC, dated May 15, 2019 (Filed With SEC on May 16, 2019)
Award Letter dated as of February 22, 2019 from the Alzheimers Association to INmune Bio, Inc (Filed With SEC on February 28, 2019)